Clinical trial
A Cluster-Randomized Trial to Evaluate the Efficacy of Wolbachia-Infected Aedes Aegypti Mosquitoes in Reducing the Incidence of Arboviral Infection in Brazil
NCT04514107 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Cluster-Randomized Trial to Evaluate the Efficacy of Wolbachia-Infected Aedes Aegypti Mosquitoes in Reducing the Incidence of Arboviral Infection in Brazil
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 9, 2020
- Completion date
- October 29, 2024
- Enrollment
- 5,757 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dengue fever